AACR-ROUND-UP: A Novel Drug Delivery System And More Liquid Biopsy Results Highlight New Orleans Meeting
Executive Summary
Highlights from the American Association for Cancer Research (AACR) Annual Meeting on April 19 include an implantable microdevice for evaluating drug efficacy in treating breast cancer tumors, as well as the latest research and innovation in liquid biopsy testing.
You may also be interested in...
Device Debuts: Medtronic, Boston Scientific, Philips, Seventh Sense, Vortex, 410 Medical
Device Debuts is a new regular feature highlighting Medtech Insight editors’ top picks of medical devices that have been commercialized for the first time in the last month. This edition features an innovative minimally invasive surgical stapler, a pain-free blood-collection device, a novel approach for collecting, and circulating tumor cells, a rapid fluid-infusion device for critically ill patients, and an EP-mapping and navigation system.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.